{
    "clinical_study": {
        "@rank": "36697", 
        "arm_group": {
            "arm_group_label": "sitagliptin, metformin, placebo", 
            "arm_group_type": "Other", 
            "description": "group- 25 patients will take sitagliptin 50 mg  and metformin 1000 mg twice in a day\ngroup- 25 patients will take placebo 50 mg and metformin 1000 mg twice in a day"
        }, 
        "brief_summary": {
            "textblock": "Glucose Variability With DPP-4 Inhibition"
        }, 
        "brief_title": "Glucose Variability With DPP-4 Inhibition", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes", 
        "condition_browse": {
            "mesh_term": "Diabetes Mellitus, Type 2"
        }, 
        "detailed_description": {
            "textblock": "Patients with Type 2 Diabetes, age 35-75y., will be included in this double blind randomized\n      placebo controlled study.\n\n      The sample size of 50  patients completing the 30 day study period is based on statistical\n      input from Merck Research Laboratories, Rahway NJ."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Type 2 diabetes\n\n          -  receiving a stable dose of metformin  \u2265 1500 mg\n\n          -  HbA1c 7,5% -10/0 %\n\n        Exclusion Criteria:\n\n          -  Type 1 diabetes\n\n          -  HbA1c < 7,5% and > 10,0%"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "35 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01751321", 
            "org_study_id": "40591"
        }, 
        "intervention": {
            "arm_group_label": "sitagliptin, metformin, placebo", 
            "description": "sitagliptin 50 / metformin 1000 twice in a day and placebo 50 mg /metformin 1000 twice in a day", 
            "intervention_name": "Sitagliptin, placebo", 
            "intervention_type": "Drug", 
            "other_name": "Januvia"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Sitagliptin", 
                "Metformin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 13, 2012", 
        "number_of_arms": "1", 
        "official_title": "Glucose Variability With DPP-4 Inhibition", 
        "overall_official": {
            "affiliation": "Scientific Clinical Center of OJSC Russian Railways", 
            "last_name": "Alexander Ametov, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Russia: Ministry of Health of the Russian Federation", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "glucose variability", 
            "safety_issue": "No", 
            "time_frame": "1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01751321"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Scientific Clinical Center of OJSC Russian Railways", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Scientific Clinical Center of OJSC Russian Railways", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}